Cancer Vaccines and Immunotherapies
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cancer Vaccines and Immunotherapy".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 38
Special Issue Editor
Interests: colorectal cancer; sarcoma; osteosarcoma; immune response; exosomes; extra cellular vesicles; tumor immunology; microRNAs; gene regulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to highlight cutting-edge research in the rapidly evolving field of cancer vaccines and immunotherapy, with a particular focus on novel vaccine strategies and immune-based treatments. We welcome original research, review articles, and perspective manuscripts that explore advancements in cancer vaccine development, immune modulation, and novel therapeutic approaches.
Topics of interest include, but are not limited to, mRNA cancer vaccines, combination immunotherapies (checkpoint inhibitors, cytokine therapies, and immune adjuvants), dendritic cell-based vaccines, tumor-derived exosome vaccines, and neoantigen-based personalized cancer vaccines.
Additionally, we encourage submissions related to tumor microenvironment modulation for vaccine efficacy, CAR-T and TCR-T cell therapies, novel adjuvants and delivery systems, and biomarker-driven predictive models for vaccine response. Emerging areas such as AI-driven vaccine design, multi-omics approaches in tumor immunology, microbiome interactions with cancer immunotherapy, and epigenetic modulation of immune responses are also highly relevant to this Special Issue.
We invite researchers and clinicians to contribute their latest findings to advance the field and improve patient outcomes. Manuscripts will undergo rigorous peer review, and we encourage timely submissions in accordance with the journal’s guidelines. We look forward to your valuable contributions and appreciate your support in advancing cancer vaccine research and tumor immunology. For any inquiries, please feel free to contact the Vaccines Editorial Office at vaccines@mdpi.com.
Prof. Dr. Subbaya Subramanian
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer vaccines
- tumor immunology
- immunotherapy
- mRNA vaccines
- neoantigen-based therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
